Cancer research , Care for children
An Unclassified Tumor — with a Precisely Targeted Therapy

Early last year, at his home in San Juan, Puerto Rico, Jesus Apolinaris Cruz’s leg hurt so much he could barely sleep. “All day, it was constant pain,” the 13-year-old recalls. His parents took him to two local pediatricians, who examined him, drew blood, and tested his platelets. No diagnosis. […]

June 6, 2017
0
Cancer research , Immunotherapy , Treatments and Procedures
Immunotherapy, Targeted Drugs, Brain Cancer Research Among Highlights at Cancer Meeting

Eagerly awaited new data from trials of immunotherapy drugs, vaccines to treat brain tumors, and improved treatments for blood cancers sparked waves of optimism at the year’s biggest cancer meeting. The 2015 annual meeting of the American Society of Clinical Oncology (ASCO) drew about 30,000 cancer specialists to Chicago May […]

June 5, 2015
0
Cancer research , Research
ASCO: New Advances in Ovarian, Prostate, Lung and Melanoma Treatment

“Science and Society” was the theme of this year’s American Society of Clinical Oncology (ASCO) 50th annual meeting. The meeting showcased  cancer research from around the world. Some new findings from Dana-Farber researchers included: Joyce Liu, MD, MPH, of the Susan F. Smith Center for Women’s Cancers reported that, in […]

June 25, 2014
0

Make An Appointment

For adults: 877-442-9599

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Catch Me if You Can: Finding Cancer Cells that Hide in Plain Sight: https://t.co/SBccqKKMmY #CarTCellTherapy https://t.co/HYTgpdbi1s
Dana-Farber @danafarber
What is chronic #GVHD and how can I manage it? https://t.co/ShjxErJLYW https://t.co/22qxgu1h74
Dana-Farber @danafarber
Doctors use a PD-L1 test to determine whether a patient may benefit from immune checkpoint inhibitors. Learn more:… https://t.co/NwZhiStver

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.